Editas Medicine, Inc., Announces Pricing of $50 Million Offering of Common Stock
CAMBRIDGE, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the pricing of an underwritten offering of 1,970,000 shares of its common stock. The gross proceeds to Editas …